×
More Charts Below
Amphastar Pharmaceuticals Total Current Assets 2012-2024 | AMPH
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Recent Trends
Amphastar Pharmaceuticals total current assets from 2012 to 2024. Total current assets can be defined as the sum of all assets that are classified as current because they will provide a benefit within one year.
Related Stocks
Company Name
Market
Cap
Teva Pharmaceutical Industries (TEVA)
$15.5B
Dr Reddy's Laboratories (RDY)
$11.4B
BridgeBio Pharma (BBIO)
$6.4B
Bausch Health Cos (BHC)
$1.9B
Supernus Pharmaceuticals (SUPN)
$1.7B
Personalis (PSNL)
$282M
Taysha Gene Therapies (TSHA)
$254M
Assembly Biosciences (ASMB)
$75M
Sol-Gel Technologies (SLGL)
$15M
Evoke Pharma (EVOK)
$3M
Teligent (TLGT)
$0M